| Literature DB >> 35900820 |
Christine Holst1,2, Dominik Stelzle3, Lien My Diep4, Felix Sukums5, Bernard Ngowi6,7, Josef Noll8,9, Andrea Sylvia Winkler1,3.
Abstract
BACKGROUND: Community health education is one of the most effective measures to increase health literacy worldwide and can contribute to the achievement of specific targets of the Sustainable Development Goal 3. Digitalized health education materials can improve health knowledge as a dimension of health literacy and play an important role in disease prevention in rural sub-Saharan settings.Entities:
Keywords: HIV/AIDS; Tanzania; cysticercosis; digital health; digital health promotion; eHealth; health education; mHealth; mobile health; mobile phone; tapeworm; tuberculosis
Mesh:
Year: 2022 PMID: 35900820 PMCID: PMC9377432 DOI: 10.2196/37666
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Figure 1Geographic location of the study site. From left to right: Tanzania within Africa and the Iringa district within Tanzania. Both illustrations are from Wikimedia Commons contributors (CC BY-SA 3.0).
Figure 2Examples of illustrations of key messages from the animations. Important key messages were, for example, “never share sharp objects” and “avoid unsafe blood transfusions” for HIV/AIDS, “cover mouth and nose with paper or cloth when coughing or sneezing” for tuberculosis, and “cook meat well” for Taenia solium cysticercosis and taeniosis. These key messages were well illustrated, narrated, and repeated in the animations.
Figure 3Screenshot of the platform.
Figure 4Flowchart of the study. The figure shows the number of households assessed for inclusion before a random generator selected the 298 households for the intervention group and 302 households for the control group. One participant per household was included in the study. Further, the figure shows the remaining participants at the 3- and 12-month assessment.
Baseline demographic characteristics of participants aged 15 to 45 years living in the intervention and control villages.
| Characteristics | Total (N=600) | Intervention (n=298) | Control (n=302) | ||||
|
| |||||||
|
| Female | 362 (60.3) | 193 (64.8) | 169 (56) | |||
|
| Male | 238 (39.7) | 105 (35.2) | 133 (44) | |||
| Age (years), mean (SD) | 30.0 (8.3) | 28.7 (8.1) | 30.8 (8.3) | ||||
|
| |||||||
|
| Migoli | 173 (28.8) | 173 (58.1) | N/Aa | |||
|
| Izazi | 125 (20.8) | 125 (41.9) | N/A | |||
|
| Idodi | 150 (25) | N/Aa | 150 (49.7) | |||
|
| Kimande | 152 (25.3) | N/A | 152 (50.3) | |||
|
| |||||||
|
| No education | 79 (13.2) | 56 (18.8) | 23 (7.6) | |||
|
| Primary School | 427 (71.2) | 181 (60.7) | 246 (81.5) | |||
|
| Secondary or higher education | 94 (15.7) | 61 (20.4) | 33 (11) | |||
|
| |||||||
|
| Petty traders | 151 (25.2) | 135 (45.3) | 16 (5.3) | |||
|
| Farmers | 321 (53.5) | 65 (21.8) | 256 (84.8) | |||
|
| Other | 128 (21.3) | 98 (32.9) | 17 (9.9) | |||
aN/A: not applicable.
Figure 5Box plot and density plots for knowledge and by disease, group, and time point: (A) HIV/AIDS, (B) tuberculosis, (C) Taenia solium cysticercosis and taeniosis.
Overall intervention effect for knowledge about the target diseases and mean percentage differences among the groups (N=600).
| Target disease and time point | Correct answers, mean (SD) | Crude difference, mean (95% CI) | Adjusted difference, mean (95% CI) | |||||||||
|
| Intervention | Control |
|
|
| |||||||
|
| <.001 | |||||||||||
|
| Baseline | 47.6 (17.4) | 48.3 (15.6) | −0.1 (−6.5 to 6.3) | 0.3 (−4.7 to 5.4) |
| ||||||
|
| 3 months | 54.7 (17.0) | 47.1 (16.6) | 8.0 (1.6 to 14.4) | 8.3 (3.2 to 13.4) |
| ||||||
|
| 12 months | 59.8 (11.9) | 50.2 (21.1) | 9.9 (3.4 to 16.3) | 10.2 (5.0 to 15.4) |
| ||||||
|
| <.001 | |||||||||||
|
| Baseline | 18.9 (16.2) | 18.3 (14.7) | 1.3 (−3.6 to 6.1) | 2.0 (−2.1 to 6.1) |
| ||||||
|
| 3 months | 34.4 (15.4) | 19.8 (15.0) | 15.2 (10.3 to 20.0) | 15.8 (11.7 to 20.0) |
| ||||||
|
| 12 months | 35.8 (11.5) | 25.1 (18.5) | 11.3 (6.3 to 16.2) | 12.0 (7.7 to 16.2) |
| ||||||
|
| <.001 | |||||||||||
|
| Baseline | 9.7 (14.9) | 7.6 (12.1) | 2.4 (−1.7 to 6.4) | 2.6 (−1.6 to 6.8) |
| ||||||
|
| 3 months | 41.0 (20.2) | 10.1 (15.1) | 31.1 (26.9 to 35.3) | 31.2 (26.9 to 35.6) |
| ||||||
|
| 12 months | 42.1 (22.0) | 11.0 (20.0) | 31.4 (26.8 to 35.9) | 31.5 (26.8 to 36.2) |
| ||||||
Intervention effect and mean percentage differences among the groups at the domain level.
| Domains and time point | Correct answers, mean (SD) | Crude difference, mean (95% CI) | Adjusted difference, mean (95% CI) | ||||||||
|
| Intervention | Control |
|
|
| ||||||
|
| |||||||||||
|
|
| .06 | |||||||||
|
|
| Baseline | 49.5 (20.0) | 47.8 (18.7) | 2.0 (−4.0 to 7.9) | 1.9 (−2.3 to 6.2) |
| ||||
|
|
| 3 months | 54.0 (19.4) | 47.8 (20.2) | 6.2 (0.2 to 12.1) | 6.0 (1.7 to 10.4) |
| ||||
|
|
| 12 months | 59.2 (16.8) | 52.5 (21.3) | 6.4 (0.4 to 12.5) | 6.4 (1.9 to 10.9) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 79.2 (33.4) | 81.1 (30.9) | −1.4 (−11.5 to 8.7) | −2.2 (−11.1 to 6.8) |
| ||||
|
|
| 3 months | 88.0 (28.3) | 71.8 (37.1) | 16.5 (6.4 to 26.7) | 15.5 (6.5 to 24.6) |
| ||||
|
|
| 12 months | 93.6 (19.0) | 75.0 (40.6) | 18.8 (8.5 to 29.1) | 17.9 (8.6 to 27.1) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 70.5 (29.5) | 73.7 (27.6) | −2.4 (−12.6 to 7.8) | −2.8 (−11.9 to 6.3) |
| ||||
|
|
| 3 months | 77.2 (25.1) | 67.3 (30.5) | 10.6 (0.4 to 20.8) | 10.1 (1.0 to 19.2) |
| ||||
|
|
| 12 months | 90.7 (18.1) | 72.8 (37.2) | 18.5 (8.1 to 28.8) | 18.1 (8.8 to 27.3) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 35.3 (19.2) | 36.8 (17.7) | −0.8 (−6.6 to 5.1) | 0.2 (−4.7 to 5.1) |
| ||||
|
|
| 3 months | 43.9 (19.1) | 37.5 (16.3) | 7.0 (1.2 to 12.8) | 7.9 (2.9 to 12.8) |
| ||||
|
|
| 12 months | 46.8 (15.6) | 39.0 (19.9) | 8.4 (2.5 to 14.2) | 9.2 (4.2 to 14.3) |
| ||||
|
| |||||||||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 17.6 (22.9) | 17.0 (17.3) | 1.6 (−2.9 to 6.1) | 2.1 (−1.7 to 6.0) |
| ||||
|
|
| 3 months | 29.6 (17.5) | 18.8 (14.5) | 11.5 (7.3 to 15.7) | 12.1 (8.5 to 15.6) |
| ||||
|
|
| 12 months | 28.7 (14) | 21.1 (16.2) | 8.5 (4.2 to 12.7) | 9.0 (5.3 to 12.6) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 14.4 (15.5) | 13.8 (13.4) | 1.3 (−3.2 to 5.7) | 1.8 (−2.1 to 5.6) |
| ||||
|
|
| 3 months | 28.7 (18.1) | 15.2 (14.5) | 14.0 (9.5 to 18.5) | 14.4 (10.5 to 18.4) |
| ||||
|
|
| 12 months | 28.1 (15.0) | 19.9 (18.4) | 8.6 (4.0 to 13.3) | 9.1 (5.0 to 13.2) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 54.8 (38.3) | 53.8 (37.4) | 2.3 (−9.0 to 13.5) | 4.5 (−6.1 to 15.0) |
| ||||
|
|
| 3 months | 82.2 (28.6) | 53.6 (38.4) | 29.5 (18.5 to 40.5) | 31.6 (21.2 to 41.9) |
| ||||
|
|
| 12 months | 89.0 (20.7) | 61.6 (40.7) | 28.4 (17.2 to 39.6) | 30.4 (19.9 to 41.0) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 13.6 (18.5) | 13.5 (16.9) | 0.5 (−4.1 to 5.1) | 1.1 (−3.0 to 5.2) |
| ||||
|
|
| 3 months | 29.2 (16.3) | 15.3 (16.2) | 14.1 (9.6 to 18.7) | 14.6 (10.5 to 18.7) |
| ||||
|
|
| 12 months | 33.2 (13.4) | 22.5 (19.8) | 10.9 (6.3 to 15.6) | 11.4 (7.3 to 15.6) |
| ||||
|
| |||||||||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 8.7 (19.4) | 4.7 (14.1) | 4.2 (−1.3 to 9.7) | 4.1 (−1.5 to 9.7) |
| ||||
|
|
| 3 months | 50.1 (28.7) | 8.3 (19.1) | 42.0 (36.2 to 47.7) | 41.7 (35.9 to 47.5) |
| ||||
|
|
| 12 months | 51.4 (27.0) | 10.0 (23.4) | 41.5 (35.4 to 47.6) | 41.2 (35.0 to 47.3) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 6.0 (9.9) | 5.6 (8.8) | 0.9 (−1.8 to 3.7) | 1.0 (−1.7 to 3.8) |
| ||||
|
|
| 3 months | 22.5 (19.9) | 7.6 (10.6) | 15.3 (12.4 to 18.3) | 15.4 (12.4 to 18.5) |
| ||||
|
|
| 12 months | 27.1 (22.2) | 8.1 (15.4) | 19.5 (16.2 to 22.8) | 19.6 (16.1 to 23.1) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 7.4 (26.2) | 5.0 (21.8) | 2.4 (−3.3 to 8.0) | 2.8 (−3.5 to 9.2) |
| ||||
|
|
| 3 months | 65.6 (47.6) | 16.2 (36.9) | 49.3 (43.2 to 55.7) | 49.5 (42.5 to 56.5) |
| ||||
|
|
| 12 months | 72.8 (44.6) | 26.0 (44.0) | 46.5 (39.0 to 53.9) | 46.7 (38.7 to 54.6) |
| ||||
|
|
| <.001 | |||||||||
|
|
| Baseline | 16.6 (24.0) | 14.0 (22.4) | 2.5 (−3.3 to 8.3) | 2.8 (−2.9 to 8.5) |
| ||||
|
|
| 3 months | 55.4 (22.7) | 14.6 (21.6) | 40.7 (34.8 to 46.5) | 40.8 (35.1 to 46.6) |
| ||||
|
|
| 12 months | 50.1 (26.4) | 13.7 (25.5) | 36.3 (30.2 to 42.5) | 36.5 (30.5 to 42.6) |
| ||||
Comparison of knowledge about the 3 target diseases, shown as mean percentage of correct answers, between participants who used the information spots (InfoSpots) and those who did not at the 12-month assessment.
| Target disease and time period | InfoSpots users (n=73), mean (SD) | Non–InfoSpots users (n=170), mean (SD) | |||
|
| |||||
|
| 3 months | 55.1 (18.0) | 53.1 (16.0) | ||
|
| 12 months | 63.6 (11.1) | 56.8 (11.6) | ||
|
| |||||
|
| 3 months | 34.8 (16.5) | 33.9 (15.1) | ||
|
| 12 months | 41.1 (11.4) | 33.6 (10.8) | ||
|
| |||||
|
| 3 months | 38.5 (20.3) | 39.9 (20.3) | ||
|
| 12 months | 50.6 (17.6) | 36.7 (21.8) | ||